This site is not optimized for mobile devices. For the best mobile experience we suggest you download our mobile app!
Download on App Store App Store Icon App Store Google Play Store Icon Google Play

5: Liver Complications, References

References Part 2, Section 5 - Liver Complications

De Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C, Baveno VII Faculty. Baveno VII - Renewing consensus in portal hypertension J Hepatol 2022 Apr;76(4):959-974. doi: 10.1016/j.jhep.2021.12.022.

EASL- EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol 2024 Jun 5:S0168-8278(24)00329-5.doi: 10.1016/j.jhep.2024.04.031. 

EASL Clinical Practice Guidelines: Management of Hepatocellular Carcinoma Journal of Hepatology 2018;69:182-236 DOI:10.1016/j.jhep.2018.03.019 easl.eu/publications/clinical-practice-guidelines/

EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis J Hepatol 2018 Aug;69(2):406-460. doi: 10.1016/j. jhep.2018.03.024.

ESPEN Practical Guideline: Clinical Nutrition in Liver Disease. Clin Nutr. 2020 Dec;39(12):3533-3562. doi: 10.1016/j.clnu.2020.09.001.

Lai JC, Tandon P, Bernal W, et al. Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. 2021 Sep;74(3):1611-1644. doi: 10.1002/hep.32049. DOI: 10.1002/hep.32049

Manzardo C, Londoño MC, Castells L, et al. Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study. Am J Transplant. 2018 Oct;18(10):2513-2522. doi: 10.1111/ajt.14996

MELD (Model for End-Stage Liver Disease) Score Calculator 12 and older www.mdcalc.com/meld-score-model-end-stage-liver-disease-12-older